Advanced Filters
noise

Asthma Clinical Trials

A listing of Asthma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 347 clinical trials

Behavioral Changes Among Asthmatic Children in Sohag Universty Hospital

Asthma is considered the most common chronic childhood disease and mainly affects children resident in urban areas. Asthma has been designated a serious public health problem due to the increase in its prevalence over the last two decades and the associated high health service costs in admissions and hospitalizations The …

4 - 12 years of age All Phase N/A

A Study to Evaluate Solriktug in Adult Participants With Asthma

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma.

18 - 75 years of age All Phase 2
C Cristina Francisco, PhD

Effects of Compression Stockings in Asthma Symptoms at Night

Nocturnal worsening of asthma is common. It is characterized by overnight exacerbation of asthma symptoms such as shortness of breath, chest tightness, coughing, and wheezing, increased need of asthma medications and airway hyperresponsiveness, and decline in lung function (1). Nocturnal asthma has been attributed in part to circadian variations in …

20 - 75 years of age All Phase N/A
R Ruchong Chen

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma

This is a multi-center, randomized, double blind, placebo-controlled study to evaluate the efficacy and safety of GR1802 injection in comparison to placebo in patients with atopic dermatitis. Patients will receive GR1802 injection or Placebo every 2 Weeks.

18 - 70 years of age All Phase 2
W Wei Lei

A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Asthma

This study is a randomized, double-blind, placebo-controlled study aimed at evaluating the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of IBI3002 multiple doses in participants with asthma. The study plans to enroll participants with asthma on stable inhaled treatment, FeNO≥25ppb at screening and randomization, elevated peripheral blood eosinophils and Pre-BD …

18 - 65 years of age All Phase 1
A Ayesha Sabir, MSPT*

Scalene Hold Relax Technique With Conventional Physical Therapy in Asthma

To determine the additional effects of scalene hold relax technique with conventional exercises on pulmonary function in asthma patients

22 - 44 years of age All Phase N/A
H Hui Shen

The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System

Severe asthma is a complex and heterogeneous disease. Patients with severe asthma can present with different types of airway inflammation, and are often accompanied by a variety of comorbidities and risk factors. Identification of potentially modifiable factors affecting prognosis, that is, "treatable characteristics", and individualized bundle management based on these …

18 - 80 years of age All Phase N/A
N Nanshan Zhong, master

A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma

This study is a phase III study of SHR-1905 in subjects with severe uncontrolled asthma. The purpose of the study is to evaluate efficacy and safety of SHR-1905 in subjects with severe uncontrolled asthma.

18 years of age All Phase 3
D Dhanya Chanumolu, MPH

Asthma Symptom Perception Study

Asthma affects 8% of the United States population ages >60 years and causes considerable harm: older adults are 4 times more likely to die from asthma and have twice the risk of hospitalization. The burden of asthma is notably greater among minoritized older adults. Research suggests that perception of expiratory …

60 years of age All Phase N/A

Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate or severe asthma. WIN378 blocks the action of a protein called TSLP which causes inflammation in the lung and may contribute to your asthma control and symptoms. The study will test …

18 - 75 years of age All Phase 2

Simplify language using AI